Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 25, 2021

View Archived Issues

Platelets release antigenic DNA in lupus

Intracranial samples give glimpse into stroke response

New phase II trial evaluates BIVV-020 in chronic inflammatory demyelinating polyneuropathy

Janssen opens phase III study of rilematovir in neonates, infants and children with RSV infection

Enrollment opens in phase II study of maralixibat for infants with biliary atresia

Phase III trial of Otividex for Meniere's disease does not meet primary endpoint

Aridis announces new inhaled antibody for COVID-19

Enrollment completed in phase II study of SSS-06 long-acting erythropoietin-stimulating protein

Pelareorep plus CAR T-cell therapy show synergistic activity in preclinical models of solid tumors

Carragelose lozenges show promising activity against respiratory viruses including SARS-CoV-2

Heparegenix patents MAP2K4 inhibitors

Shenzhen Chipscreen Biosciences identifies new THR beta agonists

Integral BioSciences divulges Chk1 inhibitors

Medshine Discovery synthesizes PARP-1 inhibitors

New PTPN11 inhibitors presented by Etern Biopharma

Salarius initiates expansion stage for phase I/II study of seclidemstat in Ewing sarcoma

Longeveron completes phase I study of Lomecel-B in hypoplastic left heart syndrome

Benitec reports interim data on pilot dosing study of BB-301 for OPMD

Constant Therapeutics initiates phase II study of TXA-27 in patients with COVID-19 in Israel

Novel model of age-related hearing loss with consistent flat cochlear epithelium phenotype

New model developed for testing drugs for Nav1.9-related neuropathic pain

Decibel Therapeutics presents DB-OTO for genetic hearing loss

Generex reports data on Ii-Key-SARS-CoV-2 vaccine in transgenic mouse model

Bacterial protease takes on "undruggable" oncoprotein

Insilico Medicine announces preclinical candidate for IPF

Locus Biosciences completes phase Ib study of LBP-EC01 bacteriophage therapy

Phase IIb interim data on mirdametinib in NF1-associated plexiform neurofibromas

Pfizer and BioNTech begin evaluation of third dose of COVID-19 vaccine

FDA approves Humira for pediatric patients with ulcerative colitis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...